Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Clinical Pathology|July 29, 2005
Change of pathology request forms can reduce unwanted requests and testsJ Bailey, A Jennings, L ParapiaEye (London, England)|February 7, 2001
Familial thrombophilia and retinal vein occlusionO Backhouse, L Parapia, I Mahomed, et al.Cancer Treatment Reports|April 1, 1980
Increased urinary beta 2-microglobulin after cancer chemotherapyJ J Fleming, L Parapia, D B Morgan, et al.European Journal of Pediatrics|July 1, 1995
Homozygous protein C deficiency--management with protein C concentrateV Baliga, R Thwaites, M L Tillyer, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Phase II trial of idarubicin in patients with advanced lymphomaH Gillies, R Liang, H Rogers, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|June 24, 2008
The usefulness of the platelet function analyser (PFA-100) in screening for underlying bleeding disorders in women with menorrhagiaS Acharya, J Barraclough, M S Ibrahim, et al.The British Journal of Dermatology|October 1, 1985
Clinical and immunohistological characterization of cutaneous lesions in chronic lymphocytic leukaemiaR Greenwood, D J Barker, F C Tring, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1980
Renal tubular damage without glomerular damage after cytotoxic drugs and aminoglycosidesJ J Fleming, J A Child, E H Cooper, et al.Hematological Oncology|November 1, 1992
A pilot study of ChlOPhEPP-B--a weekly regimen for patients with untreated advanced or recurrent Hodgkin's diseaseG M Smith, D Wright, J A Child, et al.Hematological Oncology|July 1, 1991
Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-Hodgkin's lymphoma and Hodgkin's disease. Yorkshire Regional Lymphoma and Central Lymphoma GroupsJ A Child, A V Simmons, D L Barnard, et al.Pageof 2